Work

In vitro and in vivo anti-melanoma activity of ricolinostat, a selective HDAC6 inhibitor with immunomodulatory properties.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.e21075

Authors: Fengdong Cheng, Andressa Sodre Laino, Hongwei Wang, Jie Chen, Alejandro Villagra, David Michael Woods, Jeffrey S. Weber, Steven Quayle, Simon S. Jones, Eduardo M. Sotomayor

Institutions: George Washington University, NYU Langone Health, Acetylon Pharmaceuticals (United States)

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890437330

Cites:

Cited by: 2

Related to: 10